Literature DB >> 21078766

The association between the PTPN22 C1858T polymorphism and systemic lupus erythematosus: a meta-analysis update.

W W Lea1, Y H Lee.   

Abstract

The aim of this study was to determine whether the functional protein tyrosine phosphatase nonreceptor 22 (PTPN22) C1858T polymorphism (rs2476601) confers susceptibility to systemic lupus erythematosus (SLE) in ethnically different populations. A meta-analysis was conducted on the PTPN22 C1858T polymorphism across 11 comparative studies. Meta-analysis showed an association between the PTPN22 1858T allele and SLE in all study subjects (odds ratio (OR) 1.560, 95% confidence interval (CI) 1.336, 1.822, p = 2.0 × 10(-8)). Analysis after stratification by ethnicity indicated that the PTPN22 1858T allele was significantly associated with SLE in Europeans and Hispanics (OR 1.490, 95% CI 1.280, 1.735, p = 2.0 ×10(-8); OR 2.355, 95% CI 1.644, 3.373, p = 2.9 × 10(-6)). The meta-analysis showed that the C/T + T/T genotype was associated with susceptibility to SLE in all study subjects, Europeans, and Hispanics populations, and an association between the T/T genotype with SLE in Europeans. African Americans had a much lower prevalence of the T allele (2.2%) than any other population studied, and Europeans had the highest frequency (9.5%). In conclusion, this meta-analysis confirms that the PTPN22 C1858T polymorphism is associated with SLE susceptibility in different ethnic groups, and that its prevalence is ethnicity dependent.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21078766     DOI: 10.1177/0961203310381774

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  26 in total

Review 1.  Genetic susceptibility to lupus: the biological basis of genetic risk found in B cell signaling pathways.

Authors:  Samuel E Vaughn; Leah C Kottyan; Melissa E Munroe; John B Harley
Journal:  J Leukoc Biol       Date:  2012-06-29       Impact factor: 4.962

2.  The association of SCGB3A2 polymorphisms with the risk of Graves' disease: a meta-analysis.

Authors:  Liqiong Xue; Bing Han; Chunming Pan; Huaidong Song
Journal:  Endocrine       Date:  2013-08-10       Impact factor: 3.633

3.  Role of the C1858T polymorphism of protein tyrosine phosphatase non-receptor type 22 (PTPN22) in children and adolescents with type 1 diabetes.

Authors:  A Blasetti; C Di Giulio; S Tumini; M Provenzano; D Rapino; L Comegna; G Prezioso; R Chiuri; S Franchini; F Chiarelli; L Stuppia
Journal:  Pharmacogenomics J       Date:  2016-02-23       Impact factor: 3.550

4.  Association of interleukin-1 receptor-associated kinase (IRAK1) gene polymorphisms (rs3027898, rs1059702) with systemic lupus erythematosus in a Chinese Han population.

Authors:  Yu Zhai; Ke Xu; Rui-Xue Leng; Han Cen; Wei Wang; Yan Zhu; Mo Zhou; Chen-Chen Feng; Dong-Qing Ye
Journal:  Inflamm Res       Date:  2013-02-23       Impact factor: 4.575

5.  Identification of susceptibility SNPs in CTLA-4 and PTPN22 for scleritis in Han Chinese.

Authors:  F Li; X Ma; L Du; L Shi; Q Cao; N Li; T Pang; Y Liu; A Kijlstra; P Yang
Journal:  Clin Exp Immunol       Date:  2019-04-16       Impact factor: 4.330

6.  The PTPN22 R263Q polymorphism confers protection against systemic lupus erythematosus and rheumatoid arthritis, while PTPN22 R620W confers susceptibility to Graves' disease in a Mexican population.

Authors:  Daniela Josabeth López-Cano; Daniel Cadena-Sandoval; Olga Beltrán-Ramírez; Rosa Elda Barbosa-Cobos; Fausto Sánchez-Muñoz; Luis Manuel Amezcua-Guerra; Yaneli Juárez-Vicuña; María Concepción Aguilera-Cartas; José Moreno; Jesús Bautista-Olvera; Guillermo Valencia-Pacheco; Ricardo F López-Villanueva; Julian Ramírez-Bello
Journal:  Inflamm Res       Date:  2017-05-12       Impact factor: 4.575

Review 7.  PTPN22: the archetypal non-HLA autoimmunity gene.

Authors:  Stephanie M Stanford; Nunzio Bottini
Journal:  Nat Rev Rheumatol       Date:  2014-07-08       Impact factor: 20.543

8.  Potential role of PTPN22 in ankylosing spondylitis, comment on: associations of the PTPN22 and CTLA-4 genetic polymorphisms with Taiwanese ankylosing spondylitis.

Authors:  Shan-Shan Liu; Ye Ding; Ji-Quan Lou
Journal:  Rheumatol Int       Date:  2014-04-13       Impact factor: 2.631

9.  Genetics of the type I interferon pathway in systemic lupus erythematosus.

Authors:  Yogita Ghodke-Puranik; Timothy B Niewold
Journal:  Int J Clin Rheumtol       Date:  2013-12-01

10.  Association between vitamin D receptor gene BsmI, FokI, ApaI and TaqI polymorphisms and the risk of systemic lupus erythematosus: a meta-analysis.

Authors:  Song Mao; Songming Huang
Journal:  Rheumatol Int       Date:  2013-11-09       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.